SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-21-026088
Filing Date
2021-04-08
Accepted
2021-04-08 16:57:37
Documents
2
Period of Report
2021-04-08

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2576
2 POA DOCUMENT poa.txt EX-24.3_978599 3035
  Complete submission text file 0001209191-21-026088.txt   6934
Mailing Address P.O. BOX 675614 RANCHO SANTA FE CA 92067
Business Address P.O. BOX 675614 RANCHO SANTA FE CA 92067 619-733-3852
Reneo Pharmaceuticals, Inc. (Issuer) CIK: 0001637715 (see all company filings)

IRS No.: 472309515 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 3721 VALLEY CENTRE DRIVE, SUITE 200 SAN DIEGO CA 92130
Business Address
Dube Eric M (Reporting) CIK: 0001763494 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40315 | Film No.: 21815411